Furiex Pharmaceuticals
A drug development company that is involved in compound development and collaboration activities primarily in the United States.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
$1.1b | Acquisition | ||
| Total Funding | 000k | ||
Related Content
Furiex Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative therapies to address unmet medical needs. The company operates in the pharmaceutical industry, targeting a range of therapeutic areas including oncology, pain management, and gastrointestinal disorders. Furiex primarily serves healthcare providers, hospitals, and specialty clinics. The business model revolves around research and development (R&D) of new drug candidates, followed by clinical trials, regulatory approval, and commercialization. Revenue is generated through the sale of approved drugs, licensing agreements, and milestone payments from partnerships with other pharmaceutical companies. Furiex leverages its expertise in drug development to bring new treatments to market, aiming to improve patient outcomes and quality of life.
Keywords: biopharmaceutical, oncology, pain management, gastrointestinal, R&D, clinical trials, drug development, healthcare providers, licensing, commercialization.